William W Ho

7PUBLICATIONS
47CO-AUTHORS
Molecular targetsPredictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Sensory systems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 11, 2026
NKG2D upregulation sensitizes tumors to combined anti-PD1 and anti-VEGF therapy and prevents hearing loss.

Simeng Lu, Zhenzhen Yin, Limeng Wu

|Jan 22, 2025
Targeting EPHB2/ABL1 restores antitumor immunity in preclinical models of ependymoma.

Jun Ren, Zohreh Amoozgar, Taylor P Uccello

|Jun 21, 2023
Cancer cell plasticity and MHC-II-mediated immune tolerance promote breast cancer metastasis to lymph nodes.

Pin-Ji Lei, Ethel R Pereira, Patrik Andersson

|Feb 01, 2023
Losartan controls immune checkpoint blocker-induced edema and improves survival in glioblastoma mouse models.

Meenal Datta, Sampurna Chatterjee, Elizabeth M Perez

|Nov 02, 2021
Dendritic cell paucity in mismatch repair-proficient colorectal cancer liver metastases limits immune checkpoint blockade efficacy.

William W Ho, Igor L Gomes-Santos, Shuichi Aoki

|Jul 15, 2021
Losartan prevents tumor-induced hearing loss and augments radiation efficacy in NF2 schwannoma rodent models.

Limeng Wu, Sasa Vasilijic, Yao Sun

Pageof 2

Frequent Collaborators

5 joint publications

Rakesh K Jain

4 joint publications

Ashwin S Kumar

2 joint publications

Dan G Duda

2 joint publications

Lei Xu